Relationships between tuberculosis exposure, ex vivo antigen-specific T cell responses, and delayed type hypersensitivity in point-source outbreaks. (2004)
When she did not get into medical school, Ewer pursued a career in biomedical science and became interested in infectious diseases.[2] She was interested in a career in biology for she was "fascinated by seemingly endless processes that occur in our cells and organs every second of our lives without us knowing about it.[3] Ewer earned an undergraduate degree in biomedical science, which included a year of microbiology training.[4] She then began working as a biomedical scientist at the microbiology department of the John Radcliffe Hospital in 2000,[5] before pursuing a PhD on the immunology of tuberculosis (TB).[4] Ewer earned her PhD at the Open University as a result of her research with Ajit Lalvani on novel diagnostic tools using T cells for the diagnosis of tuberculosis infection.[5]
Careeredit
Upon earning her PhD, Ewer joined the UK's Animal and Plant Health Agency where she studied the effectiveness of TB vaccines in cattle and managed the roll-out of interferon-gamma-based diagnosis for bovine TB in the UK herd for the Department for Environment, Food and Rural Affairs.[5] While in this role, she co-published Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study with Susan Liebeschuetz.[6]
In 2008, Ewer became a Senior Immunologist at Oxford University's Edward Jenner Institute for Vaccine Research.[5] While there, she continued to study the effects of TB on populations and led clinical trials in an effort to discover a vaccine for Ebola.[7] The aim of her research was to define vaccine-induced immunological parameters that correlate with protection from malaria and understand why vaccines do not always work as well as expected.[8] During the COVID-19 pandemic, she led clinical controlled trials in an effort to find a vaccine, which was published in a 2020 study titled Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.[9]
^Stokel-Walker, Chris (2020-04-10). "When Will There Be A Coronavirus Vaccine?". Esquire. Retrieved 2022-11-08.
^Stokel-Walker, Chris (2020-04-10). "When Will There Be A Coronavirus Vaccine?". Esquire. Retrieved 2022-11-08.
^ abTodd, Benjamin (20 November 2013). "Interview with malaria vaccine researcher Katie Ewer". 80000hours.org. Retrieved 21 July 2020.
^ abcd"Katie Ewer". conted.ox.ac.uk. Retrieved 21 July 2020.
^Susan Liebeschuetz; Sheila Bamber; Katie Ewer; Jonathan Deeks; Ansar A Pathan; Ajit Lalvani (1 December 2004). "Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study". The Lancet. 364 (9452): 2196–2203. doi:10.1016/S0140-6736(04)17592-2. ISSN 0140-6736. PMID 15610806. S2CID 35679204. Wikidata Q46840144.
^. ndm.ox.ac.uk. Archived from the original on 21 July 2020. Retrieved 21 July 2020.
^"Katie Ewer ASSOCIATE PROFESSOR". medsci.ox.ac.uk. Retrieved 21 July 2020.
^Pedro M Folegatti; Katie J Ewer; Parvinder K Aley; et al. (20 July 2020). "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial". The Lancet. doi:10.1016/S0140-6736(20)31604-4. ISSN 0140-6736. PMC7445431. PMID 32702298. Wikidata Q97678476.
katie, ewer, katie, jane, ewer, british, immunologist, professor, vaccine, immunology, university, oxford, jenner, institute, academic, backgroundeducationphd, immunology, 2004, open, universitythesisrelationships, between, tuberculosis, exposure, vivo, antige. Katie Jane Ewer is a British immunologist and Professor of Vaccine Immunology at the University of Oxford s Jenner Institute 1 Katie EwerAcademic backgroundEducationPhD Immunology 2004 Open UniversityThesisRelationships between tuberculosis exposure ex vivo antigen specific T cell responses and delayed type hypersensitivity in point source outbreaks 2004 Academic workInstitutionsUniversity of Oxford Contents 1 Early life and education 2 Career 3 References 4 External linksEarly life and education editWhen she did not get into medical school Ewer pursued a career in biomedical science and became interested in infectious diseases 2 She was interested in a career in biology for she was fascinated by seemingly endless processes that occur in our cells and organs every second of our lives without us knowing about it 3 Ewer earned an undergraduate degree in biomedical science which included a year of microbiology training 4 She then began working as a biomedical scientist at the microbiology department of the John Radcliffe Hospital in 2000 5 before pursuing a PhD on the immunology of tuberculosis TB 4 Ewer earned her PhD at the Open University as a result of her research with Ajit Lalvani on novel diagnostic tools using T cells for the diagnosis of tuberculosis infection 5 Career editUpon earning her PhD Ewer joined the UK s Animal and Plant Health Agency where she studied the effectiveness of TB vaccines in cattle and managed the roll out of interferon gamma based diagnosis for bovine TB in the UK herd for the Department for Environment Food and Rural Affairs 5 While in this role she co published Diagnosis of tuberculosis in South African children with a T cell based assay a prospective cohort study with Susan Liebeschuetz 6 In 2008 Ewer became a Senior Immunologist at Oxford University s Edward Jenner Institute for Vaccine Research 5 While there she continued to study the effects of TB on populations and led clinical trials in an effort to discover a vaccine for Ebola 7 The aim of her research was to define vaccine induced immunological parameters that correlate with protection from malaria and understand why vaccines do not always work as well as expected 8 During the COVID 19 pandemic she led clinical controlled trials in an effort to find a vaccine which was published in a 2020 study titled Safety and immunogenicity of the ChAdOx1 nCoV 19 vaccine against SARS CoV 2 a preliminary report of a phase 1 2 single blind randomised controlled trial 9 References edit Katie Ewer www jenner ac uk Retrieved 2022 11 08 Stokel Walker Chris 2020 04 10 When Will There Be A Coronavirus Vaccine Esquire Retrieved 2022 11 08 Stokel Walker Chris 2020 04 10 When Will There Be A Coronavirus Vaccine Esquire Retrieved 2022 11 08 a b Todd Benjamin 20 November 2013 Interview with malaria vaccine researcher Katie Ewer 80000hours org Retrieved 21 July 2020 a b c d Katie Ewer conted ox ac uk Retrieved 21 July 2020 Susan Liebeschuetz Sheila Bamber Katie Ewer Jonathan Deeks Ansar A Pathan Ajit Lalvani 1 December 2004 Diagnosis of tuberculosis in South African children with a T cell based assay a prospective cohort study The Lancet 364 9452 2196 2203 doi 10 1016 S0140 6736 04 17592 2 ISSN 0140 6736 PMID 15610806 S2CID 35679204 Wikidata Q46840144 Katie Ewer Senior Immunologist Malaria and Ebola Vaccine Trials ndm ox ac uk Archived from the original on 21 July 2020 Retrieved 21 July 2020 Katie Ewer ASSOCIATE PROFESSOR medsci ox ac uk Retrieved 21 July 2020 Pedro M Folegatti Katie J Ewer Parvinder K Aley et al 20 July 2020 Safety and immunogenicity of the ChAdOx1 nCoV 19 vaccine against SARS CoV 2 a preliminary report of a phase 1 2 single blind randomised controlled trial The Lancet doi 10 1016 S0140 6736 20 31604 4 ISSN 0140 6736 PMC 7445431 PMID 32702298 Wikidata Q97678476 External links editKatie Ewer publications indexed by Google Scholar Retrieved from https en wikipedia org w index php title Katie Ewer amp oldid 1207276495, wikipedia, wiki, book, books, library,
